Suchergebnisse

"Labelled drug-related public expenditure" is the direct expenditure explicitly labelled as related to illicit drugs by the general government of the state. As part of the reporting exercise corresponding to 2005, the European Monitoring Centre for Drugs and Drug Addiction's network of national focal points set up in the 27 European Union (EU) Member States, Norway, and the candidates countries to the EU, were requested to identify labelled drug-related public expenditure, at the country level. This was reported by 10 countries categorised according to the functions of government, amounting to a total of EUR 2.17 billion. Overall, the highest proportion of this total came within the government functions of Health (66%), and Public Order and Safety (POS) (20%). By country, the average share of GDP was 0.023% for Health, and 0.013% for POS. However, these shares varied considerably across countries, ranging from 0.00033% in Slovakia, up to 0.053% of GDP in Ireland in the case of Health, and from 0.003% in Portugal, to 0.02% in the UK, in the case of POS; almost a 161-fold difference between the highest and the lowest countries for Health, and a 6-fold difference for POS. Why do Ireland and the UK spend so much in Health and POS, or Slovakia and Portugal so little, in GDP terms? To respond to this question and to make a comprehensive assessment of drug-related public expenditure across countries, this study compared Health and POS spending and GDP in the 10 reporting countries. Results found suggest GDP to be a major determinant of the Health and POS drug-related public expenditures of a country. Labelled drug-related public expenditure showed a positive association with the GDP across the countries considered: r = 0.81 in the case of Health, and r = 0.91 for POS. The percentage change in Health and POS expenditures due to a one percent increase in GDP (the income elasticity of demand) was estimated to be 1.78% and 1.23% respectively. Being highly income elastic, Health and POS expenditures can be considered luxury goods; as a nation becomes wealthier it openly spends proportionately more on drug-related health and public order and safety interventions.

Entrevista a la autora Beatriz Gimeno, a partir de su trayectoria creativa.

Resumen El objetivo de esta investigación es analizar las representaciones del cuerpo no normativo en las obras de Jeanette Winterson (1959) Espejismos y La mujer de púrpura. En especial, el cuerpo grotesco, que se ejemplifica en figuras como la del monstruo, el freak o las personas gordas. La metodología empleada consistirá en el análisis de los personajes femeninos protagonistas, con el apoyo de textos secundarios que teorizan tanto sobre estas obras como acerca de asuntos como la reflexión sobre la diversidad corporal y el concepto de belleza en la época contemporánea. Se prestará especial atención a la posible finalidad subversiva y política que estas imágenes puedan sostener, en oposición a una belleza estándar.AbstractThe aim of this research is to analyze the representations of the non-normative body in two works by Jeanette Winterson (1959), Sexingthe Cherry and TheDaylight Gate. Especially, the grotesque body, which is exemplified in figures such as the monster, the freak or the fat people. The methodology used will consist of the analysis of the main female characters, with the support of secondary texts that theorize both about these works and about issues such as the consideration on the corporal diversity and the concept of beauty on the contemporary age. Special attention will be paid to the possible subversive and political purpose that these images may sustain, as opposed to a standard beauty.

Se trata de una reseña de la última obra de Beatriz Gimeno, un tratado sobre la lactancia materna de corte feminista.